Horizon Pharma Inc (HZNP) 18.50 $HZNP
Horizon Pharma plc Provides Update on Shareholders Meeting Related to the Proposed Acquisition of Depomed, Inc.
Marketwired - Fri Nov 13, 1:00PM CST
Horizon Pharma plc (NASDAQ: HZNP) ("Horizon Pharma"
, a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced that its shareholders have approved four of the five proposals put before them today at the extraordinary general meeting of Horizon Pharma shareholders (the "Shareholder Meeting" . Further details on the voting results for each of the proposals put before the shareholders at the Shareholder Meeting can be found on the Current Report on Form 8-K that Horizon Pharma intends to file with the Securities and Exchange Commission later today.
HZNP: 18.50 (-0.46), DEPO: 19.12 (-0.27)
Horizon Pharma plc Selected as One of Chicago Tribune's Top Workplaces in 2015
Marketwired - Fri Nov 13, 6:30AM CST
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it has been selected as one of the Chicago Tribune's 2015 Top 40 Small-to-Medium Sized Workplaces.
HZNP: 18.50 (-0.46)
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
Marketwired - Fri Nov 13, 6:00AM CST
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced the issuance of a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. patent application number 12/553,107 (U.S. publication number 2010-0062064), entitled "Method for Delivering A Pharmaceutical Composition to Patient in Need Thereof" that covers the U.S. approved medicine VIMOVO(R) (naproxen/esomeprazole) delayed release tablets.
HZNP: 18.50 (-0.46), POZN: 7.02 (-0.16)
Gilead, Regeneron Stocks Weather Drug Pricing Furor
at Investor's Business Daily - Thu Nov 12, 5:30PM CST
Recent weeks have not been friendly to the pharmaceutical industry, with some stocks in the sector such as Valeant Pharmaceuticals (VRX) and Horizon Pharma (HZNP) withering amid criticism over the industry's drug-pricing practices and fears of...
MNK: 57.30 (+0.08), ESRX: 83.94 (-0.72), VRX: 70.34 (-2.98), GILD: 104.29 (+0.48), HZNP: 18.50 (-0.46), SNY: 43.56 (+0.44), REGN: 566.90 (+8.52)
Horizon (HZNP) Slips, Comments on Express Scripts Charges
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 3:45PM CST
Horizon Pharma plc (HZNP) tumbled 19.6% after it commented on Express Scripts Holding Company's (ESRX) business practices.
VRX: 70.34 (-2.98), ESRX: 83.94 (-0.72), HZNP: 18.50 (-0.46)
Kohl's and Liberty Media are big market movers
AP - Thu Nov 12, 3:24PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
KSS: 44.19 (+0.25), BX: 31.15 (-0.23), AAP: 162.97 (-1.25), LMCK: 39.63 (-0.36), NCR: 26.77 (-0.22), TAP: 94.55 (+0.67), M: 37.79 (-0.83), HP: 54.38 (-0.74), PLKI: 53.97 (-0.70), LUX: 67.63 (-0.11), GIB: 41.67 (-0.71), ADT: 34.19 (+0.22), LMCB: 42.10 (+0.43), LMCA: 40.93 (-0.54), ANGI: 9.91 (+0.08), TAP.A: 93.17 (unch), HZNP: 18.50 (-0.46), BABA: 77.89 (-0.41)
IMPORTANT ALERT: Khang & Khang LLP Announces an Investigation of Claims against Horizon Pharma plc and Advises Shareholders to Contact the Firm
Business Wire - Wed Nov 11, 8:00PM CST
Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Horizon Pharma plc ("Horizon" or the "Company" (NASDAQ: HZNP). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.
HZNP: 18.50 (-0.46)
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Horizon Pharma plc
Business Wire - Wed Nov 11, 5:48PM CST
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Horizon Pharma plc (NASDAQ: HZNP) resulting from allegations that Horizon Pharma may have issued materially misleading business information to the investing public.
HZNP: 18.50 (-0.46)
Stocks End Modestly Lower; Popeyes Cooking After Hours
at Investor's Business Daily - Wed Nov 11, 4:15PM CST
Stocks seesawed to a lower finish on Veterans Day Wednesday. The Dow Jones industrial average, the Nasdaq and the S&P 500 all ended down 0.3%. According to preliminary data, volume was lower across the board in the stock market today. After the...
ESRX: 83.94 (-0.72), AAP: 162.97 (-1.25), AFSI: 60.55 (-0.38), HZNP: 18.50 (-0.46), LXFT: 75.40 (-0.95), PLKI: 53.97 (-0.70), XRS: 41.34 (+0.29), CSCO: 26.84 (+0.05)
Linden Care Corrects Express Scripts' Allegations
PR Newswire - Wed Nov 11, 3:11PM CST
Linden Care, LLC ("Linden Care" or the "Company" , a retail and specialty pharmacy focused on facilitating medication access and optimizing treatment outcomes for patients suffering from chronic pain, refutes all allegations from Express Scripts.
ESRX: 83.94 (-0.72), HZNP: 18.50 (-0.46)
SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims Against Horizon Pharma plc and Encourages Investors to Contact the Firm
Business Wire - Wed Nov 11, 3:04PM CST
Goldberg Law PC (http://www.Goldberglawpc.com) announces that it is investigating claims of potential misrepresentations by Horizon Pharma plc ("Horizon" or the "Company" (NASDAQ: HZNP). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.
HZNP: 18.50 (-0.46)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Horizon Pharma plc and Certain Officers and Directors-- HZNP
PR Newswire - Wed Nov 11, 2:17PM CST
Levi & Korsinsky, LLP announces that it has commenced an investigation of Horizon Pharma plc ("Horizon Pharma" or the "Company" (NASDAQGS: HZNP) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.
HZNP: 18.50 (-0.46)
Why Horizon Pharma Is Crashing Today
Todd Campbell, The Motley Fool - Motley Fool - Wed Nov 11, 1:17PM CST
What: News that the nation's largest pharmacy benefit manager is severing ties with a specialty pharmacy that fills prescriptions for Horizon Pharma sent Horizon tumbling by 18% earlier today. So what: Pharmaceutical companies that acquire,...
ESRX: 83.94 (-0.72), HZNP: 18.50 (-0.46)
Jim Cramer Says Amazon Rules This Holiday Season, Bah Humbug Macy's
at The Street - Wed Nov 11, 12:20PM CST
Amazon is expected to go higher this holiday season, because the company's business model is so good.
AGN: 296.42 (-2.29), AMZN: 642.31 (-5.50), GE: 30.03 (-0.33), ESRX: 83.94 (-0.72), SHAK: 42.29 (-1.13), NKE: 122.19 (-1.27), HZNP: 18.50 (-0.46), JCP: 7.40 (-0.23), MCD: 110.82 (-0.24), M: 37.79 (-0.83), JWN: 54.27 (-0.46), SYF: 30.65 (+0.36), TIF: 73.80 (-1.43), AAPL: 113.63 (-0.55)
Horizon Pharma (HZNP) Stock Plummets as Express Scripts Severs Ties
at The Street - Wed Nov 11, 12:02PM CST
Horizon Pharma (HZNP) stock is diving in early afternoon trading on Wednesday, after Express Scripts (ESRX) removed the company's Linden Care pharmacy from its network.
HZNP: 18.50 (-0.46)
Horizon Slams Express Scripts Amid Pharmacy Dispute
at Investor's Business Daily - Wed Nov 11, 9:50AM CST
Specialty drugmaker Horizon Pharma (HZNP) fell sharply in early trading Wednesday after pharmacy benefit manager Express Scripts (ESRX) sued it for allegedly unpaid rebates and cut a specialty pharmacy Horizon had been using out of its network....
VRX: 70.34 (-2.98), ESRX: 83.94 (-0.72), HZNP: 18.50 (-0.46), CVS: 93.80 (+0.18), DEPO: 19.12 (-0.27)
Stock Futures Climb Toward Open; Facebook, LinkedIn, Alphabet Rise
at Investor's Business Daily - Wed Nov 11, 7:52AM CST
Stock futures built on early gains ahead of Wednesday's open. Dow futures were ahead 76.8 points and climbing. Nasdaq 100 futures traded up 23.7 points. S&P 500 futures rose a strong 7.9 points. The stock market today is open, but bond traders are...
BUD: 124.57 (+2.18), CNX: 7.75 (-0.21), FB: 104.81 (+0.77), M: 37.79 (-0.83), ESRX: 83.94 (-0.72), LNKD: 244.91 (-1.57), HZNP: 18.50 (-0.46), JCP: 7.40 (-0.23), GOOGL: 745.91 (-4.51), SNY: 43.56 (+0.44), AAPL: 113.63 (-0.55), REGN: 566.90 (+8.52), CSCO: 26.84 (+0.05)
Horizon Pharma plc Provides Comment on Express Scripts' Business Practices
Marketwired - Wed Nov 11, 6:18AM CST
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today commented on Express Scripts' business practices.
ESRX: 83.94 (-0.72), HZNP: 18.50 (-0.46)
Horizon Pharma plc Announces Collaboration With Alliance for Lupus Research to Study RAYOS(R) (prednisone) Delayed-Release Tablets in Systemic Lupus Erythematosus
Marketwired - Wed Nov 11, 6:00AM CST
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced a collaboration with the Alliance for Lupus Research (ALR) to study RAYOS(R) (prednisone) delayed-release tablets in systemic lupus erythematosus (SLE), a chronic autoimmune disease that causes inflammation and pain in the joints and muscles as well as overall fatigue.
HZNP: 18.50 (-0.46)
Horizon Pharma plc Responds to Express Scripts Lawsuit and Recent Allegations
Marketwired - Tue Nov 10, 9:23PM CST
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, responded to a lawsuit filed by Express Scripts and recent allegations:
ESRX: 83.94 (-0.72), HZNP: 18.50 (-0.46)
Horizon Pharma plc Provides Update on Shareholders Meeting Related to the Proposed Acquisition of Depomed, Inc.
Marketwired - Fri Nov 13, 1:00PM CST
Horizon Pharma plc (NASDAQ: HZNP) ("Horizon Pharma"
, a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced that its shareholders have approved four of the five proposals put before them today at the extraordinary general meeting of Horizon Pharma shareholders (the "Shareholder Meeting" . Further details on the voting results for each of the proposals put before the shareholders at the Shareholder Meeting can be found on the Current Report on Form 8-K that Horizon Pharma intends to file with the Securities and Exchange Commission later today. HZNP: 18.50 (-0.46), DEPO: 19.12 (-0.27)
Horizon Pharma plc Selected as One of Chicago Tribune's Top Workplaces in 2015
Marketwired - Fri Nov 13, 6:30AM CST
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that it has been selected as one of the Chicago Tribune's 2015 Top 40 Small-to-Medium Sized Workplaces.
HZNP: 18.50 (-0.46)
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
Marketwired - Fri Nov 13, 6:00AM CST
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced the issuance of a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. patent application number 12/553,107 (U.S. publication number 2010-0062064), entitled "Method for Delivering A Pharmaceutical Composition to Patient in Need Thereof" that covers the U.S. approved medicine VIMOVO(R) (naproxen/esomeprazole) delayed release tablets.
HZNP: 18.50 (-0.46), POZN: 7.02 (-0.16)
Gilead, Regeneron Stocks Weather Drug Pricing Furor
at Investor's Business Daily - Thu Nov 12, 5:30PM CST
Recent weeks have not been friendly to the pharmaceutical industry, with some stocks in the sector such as Valeant Pharmaceuticals (VRX) and Horizon Pharma (HZNP) withering amid criticism over the industry's drug-pricing practices and fears of...
MNK: 57.30 (+0.08), ESRX: 83.94 (-0.72), VRX: 70.34 (-2.98), GILD: 104.29 (+0.48), HZNP: 18.50 (-0.46), SNY: 43.56 (+0.44), REGN: 566.90 (+8.52)
Horizon (HZNP) Slips, Comments on Express Scripts Charges
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 3:45PM CST
Horizon Pharma plc (HZNP) tumbled 19.6% after it commented on Express Scripts Holding Company's (ESRX) business practices.
VRX: 70.34 (-2.98), ESRX: 83.94 (-0.72), HZNP: 18.50 (-0.46)
Kohl's and Liberty Media are big market movers
AP - Thu Nov 12, 3:24PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
KSS: 44.19 (+0.25), BX: 31.15 (-0.23), AAP: 162.97 (-1.25), LMCK: 39.63 (-0.36), NCR: 26.77 (-0.22), TAP: 94.55 (+0.67), M: 37.79 (-0.83), HP: 54.38 (-0.74), PLKI: 53.97 (-0.70), LUX: 67.63 (-0.11), GIB: 41.67 (-0.71), ADT: 34.19 (+0.22), LMCB: 42.10 (+0.43), LMCA: 40.93 (-0.54), ANGI: 9.91 (+0.08), TAP.A: 93.17 (unch), HZNP: 18.50 (-0.46), BABA: 77.89 (-0.41)
IMPORTANT ALERT: Khang & Khang LLP Announces an Investigation of Claims against Horizon Pharma plc and Advises Shareholders to Contact the Firm
Business Wire - Wed Nov 11, 8:00PM CST
Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Horizon Pharma plc ("Horizon" or the "Company"
(NASDAQ: HZNP). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors. HZNP: 18.50 (-0.46)
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Horizon Pharma plc
Business Wire - Wed Nov 11, 5:48PM CST
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Horizon Pharma plc (NASDAQ: HZNP) resulting from allegations that Horizon Pharma may have issued materially misleading business information to the investing public.
HZNP: 18.50 (-0.46)
Stocks End Modestly Lower; Popeyes Cooking After Hours
at Investor's Business Daily - Wed Nov 11, 4:15PM CST
Stocks seesawed to a lower finish on Veterans Day Wednesday. The Dow Jones industrial average, the Nasdaq and the S&P 500 all ended down 0.3%. According to preliminary data, volume was lower across the board in the stock market today. After the...
ESRX: 83.94 (-0.72), AAP: 162.97 (-1.25), AFSI: 60.55 (-0.38), HZNP: 18.50 (-0.46), LXFT: 75.40 (-0.95), PLKI: 53.97 (-0.70), XRS: 41.34 (+0.29), CSCO: 26.84 (+0.05)
Linden Care Corrects Express Scripts' Allegations
PR Newswire - Wed Nov 11, 3:11PM CST
Linden Care, LLC ("Linden Care" or the "Company"
, a retail and specialty pharmacy focused on facilitating medication access and optimizing treatment outcomes for patients suffering from chronic pain, refutes all allegations from Express Scripts. ESRX: 83.94 (-0.72), HZNP: 18.50 (-0.46)
SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims Against Horizon Pharma plc and Encourages Investors to Contact the Firm
Business Wire - Wed Nov 11, 3:04PM CST
Goldberg Law PC (http://www.Goldberglawpc.com) announces that it is investigating claims of potential misrepresentations by Horizon Pharma plc ("Horizon" or the "Company"
(NASDAQ: HZNP). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors. HZNP: 18.50 (-0.46)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Horizon Pharma plc and Certain Officers and Directors-- HZNP
PR Newswire - Wed Nov 11, 2:17PM CST
Levi & Korsinsky, LLP announces that it has commenced an investigation of Horizon Pharma plc ("Horizon Pharma" or the "Company"
(NASDAQGS: HZNP) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors. HZNP: 18.50 (-0.46)
Why Horizon Pharma Is Crashing Today
Todd Campbell, The Motley Fool - Motley Fool - Wed Nov 11, 1:17PM CST
What: News that the nation's largest pharmacy benefit manager is severing ties with a specialty pharmacy that fills prescriptions for Horizon Pharma sent Horizon tumbling by 18% earlier today. So what: Pharmaceutical companies that acquire,...
ESRX: 83.94 (-0.72), HZNP: 18.50 (-0.46)
Jim Cramer Says Amazon Rules This Holiday Season, Bah Humbug Macy's
at The Street - Wed Nov 11, 12:20PM CST
Amazon is expected to go higher this holiday season, because the company's business model is so good.
AGN: 296.42 (-2.29), AMZN: 642.31 (-5.50), GE: 30.03 (-0.33), ESRX: 83.94 (-0.72), SHAK: 42.29 (-1.13), NKE: 122.19 (-1.27), HZNP: 18.50 (-0.46), JCP: 7.40 (-0.23), MCD: 110.82 (-0.24), M: 37.79 (-0.83), JWN: 54.27 (-0.46), SYF: 30.65 (+0.36), TIF: 73.80 (-1.43), AAPL: 113.63 (-0.55)
Horizon Pharma (HZNP) Stock Plummets as Express Scripts Severs Ties
at The Street - Wed Nov 11, 12:02PM CST
Horizon Pharma (HZNP) stock is diving in early afternoon trading on Wednesday, after Express Scripts (ESRX) removed the company's Linden Care pharmacy from its network.
HZNP: 18.50 (-0.46)
Horizon Slams Express Scripts Amid Pharmacy Dispute
at Investor's Business Daily - Wed Nov 11, 9:50AM CST
Specialty drugmaker Horizon Pharma (HZNP) fell sharply in early trading Wednesday after pharmacy benefit manager Express Scripts (ESRX) sued it for allegedly unpaid rebates and cut a specialty pharmacy Horizon had been using out of its network....
VRX: 70.34 (-2.98), ESRX: 83.94 (-0.72), HZNP: 18.50 (-0.46), CVS: 93.80 (+0.18), DEPO: 19.12 (-0.27)
Stock Futures Climb Toward Open; Facebook, LinkedIn, Alphabet Rise
at Investor's Business Daily - Wed Nov 11, 7:52AM CST
Stock futures built on early gains ahead of Wednesday's open. Dow futures were ahead 76.8 points and climbing. Nasdaq 100 futures traded up 23.7 points. S&P 500 futures rose a strong 7.9 points. The stock market today is open, but bond traders are...
BUD: 124.57 (+2.18), CNX: 7.75 (-0.21), FB: 104.81 (+0.77), M: 37.79 (-0.83), ESRX: 83.94 (-0.72), LNKD: 244.91 (-1.57), HZNP: 18.50 (-0.46), JCP: 7.40 (-0.23), GOOGL: 745.91 (-4.51), SNY: 43.56 (+0.44), AAPL: 113.63 (-0.55), REGN: 566.90 (+8.52), CSCO: 26.84 (+0.05)
Horizon Pharma plc Provides Comment on Express Scripts' Business Practices
Marketwired - Wed Nov 11, 6:18AM CST
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today commented on Express Scripts' business practices.
ESRX: 83.94 (-0.72), HZNP: 18.50 (-0.46)
Horizon Pharma plc Announces Collaboration With Alliance for Lupus Research to Study RAYOS(R) (prednisone) Delayed-Release Tablets in Systemic Lupus Erythematosus
Marketwired - Wed Nov 11, 6:00AM CST
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced a collaboration with the Alliance for Lupus Research (ALR) to study RAYOS(R) (prednisone) delayed-release tablets in systemic lupus erythematosus (SLE), a chronic autoimmune disease that causes inflammation and pain in the joints and muscles as well as overall fatigue.
HZNP: 18.50 (-0.46)
Horizon Pharma plc Responds to Express Scripts Lawsuit and Recent Allegations
Marketwired - Tue Nov 10, 9:23PM CST
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, responded to a lawsuit filed by Express Scripts and recent allegations:
ESRX: 83.94 (-0.72), HZNP: 18.50 (-0.46)
